Crossmark

Role of RNA modifications in cancer

Crossref DOI link: https://doi.org/10.1038/s41568-020-0253-2

Published Online: 2020-04-16

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barbieri, Isaia https://orcid.org/0000-0003-3035-8970
Kouzarides, Tony https://orcid.org/0000-0002-8918-4162
License Information

Text and Data Mining valid from 2020-04-16

Version of Record valid from 2020-04-16
More Information

Article History

Accepted: 10 March 2020

First Online: 16 April 2020

Competing interests

: T.K. is a co-founder of Abcam and Storm Therapeutics, Cambridge, UK. I.B. declares no competing interests.